Brian Hilbush is a genomics and artificial intelligence expert with 3 decades of scientific and technical management experience in the life sciences. He is the author of “In Silico Dreams: How Artificial Intelligence and Biotechnology Will Create the Medicines of the Future” (Wiley, 2021). The book encapsulates his passion for these disciplines and conveys his thesis that their convergence will accelerate an engineering-based approach toward therapeutic development.Brian recently founded 2 startups in the AI space. He is CEO of Periscope AI, a company that provides AI strategy consulting and applications development support for SMBs across a range of industries. He is also launching DeepBio Labs, an enterprise software company that is building a platform for biopharma investors and clinical development. The company aims to use AI models to rigorously evaluate clinical assets, drug targets and intervention hypotheses across the entire global pharmaceutical pipeline.Dr. Hilbush was co-founder or a founding scientist at several startups in biotech and software, each of which were financed at early stages by utilizing funds from bootstrapping, private investors, venture capital or corporate VCs. He has built his business experience around multidisciplinary team building, executive roles in R&D, product development and corporate strategy.Brian’s vision and experience in combining scientific innovations with computational methods has been instrumental in technology commercialization, product innovation and engineering projects that have been first to market in life science tools, drug discovery and analytical pipelines.